Terry Mary Beth, English Dallas R, Freudenheim Jo L, Lauby-Secretan Béatrice, Gapstur Susan M
Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, Columbia University, New York, NY, USA.
Cancer Council Victoria and Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Breast Cancer Res. 2024 Dec 5;26(1):179. doi: 10.1186/s13058-024-01937-z.
Because alcohol consumption is an established cause of female breast cancer, understanding whether cessation affects risk is of public health importance. In a recent meta-analysis, compared with continuing consumption, the relative risk (RR) for cessation was 0.95 (95% confidence interval [CI] 0.88-1.01). Because intake of alcohol is more consistently associated with estrogen receptor positive (ER+) than negative (ER-) subtypes, we conducted a meta-analysis of alcohol cessation for ER-specific breast cancer risk using data from three cohort studies and one population-based case-control study (ER + n = 3,793; ER- n = 627) with information reported on cessation and ER status. Compared with continuing consumption, cessation was associated with lower risk of ER+ (RR = 0.88, 95%CI, 0.79-0.98) but not ER- (RR = 1.23, 95%CI, 0.98-1.55) breast cancer. These results suggest that, compared with continuing consumption, alcohol cessation may reduce ER + but not ER- breast cancer risk. However, research that considers duration of cessation is warranted.
由于饮酒是女性乳腺癌的既定病因,了解戒酒是否会影响患病风险具有公共卫生意义。在最近的一项荟萃分析中,与持续饮酒相比,戒酒的相对风险(RR)为0.95(95%置信区间[CI]0.88 - 1.01)。由于酒精摄入量与雌激素受体阳性(ER+)亚型的关联比与阴性(ER-)亚型更为一致,我们利用三项队列研究和一项基于人群的病例对照研究(ER+ n = 3793;ER- n = 627)中报告的戒酒和ER状态信息,对特定ER乳腺癌风险的戒酒情况进行了荟萃分析。与持续饮酒相比,戒酒与ER+乳腺癌风险降低相关(RR = 0.88,95%CI,0.79 - 0.98),但与ER-乳腺癌风险无关(RR = 1.23,95%CI,0.98 - 1.55)。这些结果表明,与持续饮酒相比,戒酒可能会降低ER+乳腺癌风险,但不会降低ER-乳腺癌风险。然而,有必要开展考虑戒酒时长的研究。